{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:17:56Z","timestamp":1790306276934,"version":"4.1.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11883-025-01342-7","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:37:54Z","timestamp":1762763874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Beyond LDL Cholesterol Reduction: Pleiotropic Profiling of Statins"],"prefix":"10.1007","volume":"27","author":[{"given":"Tanesh","family":"Ayyalu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia","family":"Bimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya S.","family":"Safarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohaib M.","family":"Bagha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"1342_CR1","doi-asserted-by":"publisher","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al.\u00a02018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082\u2013e143. https:\/\/doi.org\/10.1161\/CIR.0000000000000625","DOI":"10.1161\/CIR.0000000000000625"},{"issue":"8","key":"1342_CR2","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2025;151(8):e41-660. https:\/\/doi.org\/10.1161\/CIR.0000000000001303.","journal-title":"Circulation"},{"issue":"23","key":"1342_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK, Atherothrombosis, LTNo. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129\u201338. https:\/\/doi.org\/10.1016\/j.jacc.2009.09.009.","journal-title":"J Am Coll Cardiol"},{"issue":"32","key":"1342_CR4","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2017;38(32):2459\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144.","journal-title":"Eur Heart J"},{"issue":"12","key":"1342_CR5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"issue":"23 Suppl 1","key":"1342_CR6","doi-asserted-by":"publisher","first-page":"III39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(23 Suppl 1):III39-43. https:\/\/doi.org\/10.1161\/01.CIR.0000131517.20177.5a.","journal-title":"Circulation"},{"key":"1342_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89\u2013118. https:\/\/doi.org\/10.1146\/annurev.pharmtox.45.120403.095748.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"21","key":"1342_CR8","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195\u2013207. https:\/\/doi.org\/10.1056\/NEJMoa0807646.","journal-title":"N Engl J Med"},{"issue":"4","key":"1342_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11239-012-0687-9","volume":"33","author":"AL Rodriguez","year":"2012","unstructured":"Rodriguez AL, Wojcik BM, Wrobleski SK, Myers DD Jr., Wakefield TW, Diaz JA. Statins, inflammation and deep vein thrombosis: a systematic review. J Thromb Thrombolysis. 2012;33(4):371\u201382. https:\/\/doi.org\/10.1007\/s11239-012-0687-9.","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"1342_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2174\/1570159X12666140923210929","volume":"12","author":"J Zhao","year":"2014","unstructured":"Zhao J, Zhang X, Dong L, Wen Y, Cui L. The many roles of Statins in ischemic stroke. Curr Neuropharmacol. 2014;12(6):564\u201374. https:\/\/doi.org\/10.2174\/1570159X12666140923210929.","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"1342_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"K Koushki","year":"2021","unstructured":"Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, et al. Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol. 2021;60(2):175\u201399. https:\/\/doi.org\/10.1007\/s12016-020-08791-9.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1\u20133","key":"1342_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejphar.2012.06.022","volume":"691","author":"SA Zaitone","year":"2012","unstructured":"Zaitone SA, Abo-Gresha NM. Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF. Eur J Pharmacol. 2012;691(1\u20133):134\u201342. https:\/\/doi.org\/10.1016\/j.ejphar.2012.06.022.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1342_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0008-6363(01)00306-6","volume":"51","author":"P Di Napoli","year":"2001","unstructured":"Di Napoli P, Antonio Taccardi A, Grilli A, Spina R, Felaco M, Barsotti A, et al. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc Res. 2001;51(2):283\u201393. https:\/\/doi.org\/10.1016\/s0008-6363(01)00306-6.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"1342_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/hc0702.104164","volume":"105","author":"S Hayashidani","year":"2002","unstructured":"Hayashidani S, Tsutsui H, Shiomi T, Suematsu N, Kinugawa S, Ide T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation. 2002;105(7):868\u201373. https:\/\/doi.org\/10.1161\/hc0702.104164.","journal-title":"Circulation"},{"key":"1342_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122051","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Hajighasemi S, Banach M, Penson PE, Jamialahmadi T, et al. Statin-induced nitric oxide signaling: mechanisms and therapeutic implications. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8122051.","journal-title":"J Clin Med"},{"issue":"1","key":"1342_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1021\/cb500791f","volume":"10","author":"CC Palsuledesai","year":"2015","unstructured":"Palsuledesai CC, Distefano MD. Protein prenylation: enzymes, therapeutics, and biotechnology applications. ACS Chem Biol. 2015;10(1):51\u201362. https:\/\/doi.org\/10.1021\/cb500791f.","journal-title":"ACS Chem Biol"},{"issue":"3","key":"1342_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","volume":"63","author":"SJ McTaggart","year":"2006","unstructured":"McTaggart SJ. Isoprenylated proteins. Cell Mol Life Sci. 2006;63(3):255\u201367. https:\/\/doi.org\/10.1007\/s00018-005-5298-6.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1342_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0167-5273(02)00195-x","volume":"86","author":"JK Liao","year":"2002","unstructured":"Liao JK. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002;86(1):5\u201318. https:\/\/doi.org\/10.1016\/s0167-5273(02)00195-x.","journal-title":"Int J Cardiol"},{"issue":"37","key":"1342_CR19","doi-asserted-by":"publisher","first-page":"24266","DOI":"10.1074\/jbc.273.37.24266","volume":"273","author":"U Laufs","year":"1998","unstructured":"Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem. 1998;273(37):24266\u201371. https:\/\/doi.org\/10.1074\/jbc.273.37.24266.","journal-title":"J Biol Chem"},{"issue":"4","key":"1342_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/s0008-6363(00)00146-2","volume":"47","author":"KK Koh","year":"2000","unstructured":"Koh KK. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res. 2000;47(4):648\u201357. https:\/\/doi.org\/10.1016\/s0008-6363(00)00146-2.","journal-title":"Cardiovasc Res"},{"issue":"10","key":"1342_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.5551\/jat.24398","volume":"21","author":"S Lim","year":"2014","unstructured":"Lim S, Barter P. Antioxidant effects of statins in the management of cardiometabolic disorders. J Atheroscler Thromb. 2014;21(10):997\u20131010. https:\/\/doi.org\/10.5551\/jat.24398.","journal-title":"J Atheroscler Thromb"},{"issue":"8","key":"1342_CR22","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1089\/ars.2013.5430","volume":"20","author":"M Margaritis","year":"2014","unstructured":"Margaritis M, Channon KM, Antoniades C. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering. Antioxid Redox Signal. 2014;20(8):1198\u2013215. https:\/\/doi.org\/10.1089\/ars.2013.5430.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"1342_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","volume":"28","author":"J Greenwood","year":"2007","unstructured":"Greenwood J, Mason JC. Statins and the vascular endothelial inflammatory response. Trends Immunol. 2007;28(2):88\u201398. https:\/\/doi.org\/10.1016\/j.it.2006.12.003.","journal-title":"Trends Immunol"},{"issue":"5","key":"1342_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/01.RES.0000258492.96097.47","volume":"100","author":"WT Gerthoffer","year":"2007","unstructured":"Gerthoffer WT. Mechanisms of vascular smooth muscle cell migration. Circ Res. 2007;100(5):607\u201321. https:\/\/doi.org\/10.1161\/01.RES.0000258492.96097.47.","journal-title":"Circ Res"},{"issue":"13","key":"1342_CR25","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/cvr\/cvab303","volume":"117","author":"P Libby","year":"2021","unstructured":"Libby P. Inflammation during the life cycle of the atherosclerotic plaque. Cardiovasc Res. 2021;117(13):2525\u201336. https:\/\/doi.org\/10.1093\/cvr\/cvab303.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1342_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/01.cir.98.1.82","volume":"98","author":"RC Braun-Dullaeus","year":"1998","unstructured":"Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation. 1998;98(1):82\u20139. https:\/\/doi.org\/10.1161\/01.cir.98.1.82.","journal-title":"Circulation"},{"issue":"2","key":"1342_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1568006043586134","volume":"5","author":"W Erl","year":"2005","unstructured":"Erl W. Statin-induced vascular smooth muscle cell apoptosis: a possible role in the prevention of restenosis? Curr Drug Targets Cardiovasc Haematol Disord. 2005;5(2):135\u201344. https:\/\/doi.org\/10.2174\/1568006043586134.","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"issue":"8","key":"1342_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/00001721-199611000-00005","volume":"7","author":"F Dol","year":"1996","unstructured":"Dol F, Mares A, Herbert J. Simvastatin inhibits myointimal hyperplasia following carotid artery injury in cholesterol-fed rabbits. Blood Coagul Fibrinolysis. 1996;7(8):772\u20138. https:\/\/doi.org\/10.1097\/00001721-199611000-00005.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"1342_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1161\/01.ATV.0000068646.76823.AE","volume":"23","author":"Z Luan","year":"2003","unstructured":"Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and \u2013\u20099 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 2003;23(5):769\u201375. https:\/\/doi.org\/10.1161\/01.ATV.0000068646.76823.AE.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1342_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/01.fjc.0000137162.14735.30","volume":"44","author":"S Wolfrum","year":"2004","unstructured":"Wolfrum S, Dendorfer A, Schutt M, Weidtmann B, Heep A, Tempel K, et al. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase\/Akt pathway. J Cardiovasc Pharmacol. 2004;44(3):348\u201355. https:\/\/doi.org\/10.1097\/01.fjc.0000137162.14735.30.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"1342_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-2004-869594","volume":"4","author":"S Mital","year":"2004","unstructured":"Mital S, Liao JK. Statins and the myocardium. Semin Vasc Med. 2004;4(4):377\u201384. https:\/\/doi.org\/10.1055\/s-2004-869594.","journal-title":"Semin Vasc Med"},{"issue":"1","key":"1342_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0735-1097(97)00129-0","volume":"30","author":"I Aoki","year":"1997","unstructured":"Aoki I, Aoki N, Kawano K, Shimoyama K, Maki A, Homori M, et al. Platelet-dependent thrombin generation in patients with hyperlipidemia. J Am Coll Cardiol. 1997;30(1):91\u20136. https:\/\/doi.org\/10.1016\/s0735-1097(97)00129-0.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1342_CR33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2010.10.006","volume":"214","author":"L Puccetti","year":"2011","unstructured":"Puccetti L, Santilli F, Pasqui AL, Lattanzio S, Liani R, Ciani F, et al. Effects of Atorvastatin and Rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. Atherosclerosis. 2011;214(1):122\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.10.006.","journal-title":"Atherosclerosis"},{"key":"1342_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6661847","volume":"2021","author":"A Nenna","year":"2021","unstructured":"Nenna A, Nappi F, Lusini M, Satriano UM, Schilir\u00f2 D, Spadaccio C, et al. Effect of statins on platelet activation and function: from molecular pathways to clinical effects. BioMed Res Int. 2021;2021:6661847. https:\/\/doi.org\/10.1155\/2021\/6661847.","journal-title":"BioMed Res Int"},{"issue":"10","key":"1342_CR35","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1161\/01.RES.0000268411.49545.9c","volume":"100","author":"M Yano","year":"2007","unstructured":"Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, et al. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1\/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res. 2007;100(10):1442\u201351. https:\/\/doi.org\/10.1161\/01.RES.0000268411.49545.9c.","journal-title":"Circ Res"},{"issue":"2","key":"1342_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.atherosclerosis.2011.06.009","volume":"218","author":"A Pucci","year":"2011","unstructured":"Pucci A, Formato L, Muscio M, Brscic E, Pizzimenti S, Ferroni F, et al. PPAR\u03b3 in coronary atherosclerosis: in vivo expression pattern and correlations with hyperlipidemic status and statin treatment. Atherosclerosis. 2011;218(2):479\u201385. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.06.009.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1342_CR37","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/ATVBAHA.108.183160","volume":"29","author":"FY Ali","year":"2009","unstructured":"Ali FY, Armstrong PC, Dhanji AR, Tucker AT, Paul-Clark MJ, Mitchell JA, et al. Antiplatelet actions of statins and fibrates are mediated by PPARs. Arterioscler Thromb Vasc Biol. 2009;29(5):706\u201311. https:\/\/doi.org\/10.1161\/ATVBAHA.108.183160.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"1342_CR38","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/CIRCULATIONAHA.118.035906","volume":"141","author":"L Tian","year":"2020","unstructured":"Tian L, Oikonomopoulos A, Liu C, Kitani T, Shrestha R, Chen CL, et al. Molecular signatures of beneficial class effects of statins on human induced pluripotent stem cell-derived cardiomyocytes. Circulation. 2020;141(14):1208\u201310. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035906.","journal-title":"Circulation"},{"issue":"14","key":"1342_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025408","volume":"11","author":"C Shimizu","year":"2022","unstructured":"Shimizu C, Kim J, He M, Tremoulet AH, Hoffman HM, Shyy JY, et al. RNA sequencing reveals beneficial effects of Atorvastatin on endothelial cells in acute Kawasaki disease. J Am Heart Assoc. 2022;11(14):e025408. https:\/\/doi.org\/10.1161\/JAHA.122.025408.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"1342_CR40","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/cvr\/cvaa188","volume":"117","author":"E Ehinger","year":"2021","unstructured":"Ehinger E, Ghosheh Y, Pramod AB, Lin J, Hanna DB, Mueller K, et al. Classical monocyte transcriptomes reveal significant anti-inflammatory statin effect in women with chronic HIV. Cardiovasc Res. 2021;117(4):1166\u201377. https:\/\/doi.org\/10.1093\/cvr\/cvaa188.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1342_CR41","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3892\/or.2020.7810","volume":"44","author":"C Chen","year":"2020","unstructured":"Chen C, Wu H, Kong D, Xu Y, Zhang Z, Chen F, et al. Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer. Oncol Rep. 2020;44(6):2569\u201380. https:\/\/doi.org\/10.3892\/or.2020.7810.","journal-title":"Oncol Rep"},{"key":"1342_CR42","doi-asserted-by":"crossref","unstructured":"Ayoola Awosika AEO, Uzochukwu Adabanya N, Anand. and Richard M. Millis. Statins and epigenetics: A putative mechanism for explaining pleiotropic effects. Statins - From Lipid-Lowering Benefits to Pleiotropic Effects. IntechOpen; 2023.","DOI":"10.5772\/intechopen.1001141"},{"issue":"11","key":"1342_CR43","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/gim.2014.41","volume":"16","author":"WJ Canestaro","year":"2014","unstructured":"Canestaro WJ, Austin MA, Thummel KE. Genetic factors affecting statin concentrations and subsequent myopathy: a hugenet systematic review. Genet Med. 2014;16(11):810\u20139. https:\/\/doi.org\/10.1038\/gim.2014.41.","journal-title":"Genet Med"},{"key":"1342_CR44","doi-asserted-by":"publisher","first-page":"44219","DOI":"10.1038\/srep44219","volume":"7","author":"H Gbelcova","year":"2017","unstructured":"Gbelcova H, Rimpelova S, Ruml T, Fenclova M, Kosek V, Hajslova J, et al. Variability in statin-induced changes in gene expression profiles of pancreatic cancer. Sci Rep. 2017;7:44219. https:\/\/doi.org\/10.1038\/srep44219.","journal-title":"Sci Rep"},{"issue":"10","key":"1342_CR45","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jacc.2015.12.060","volume":"67","author":"P Wurtz","year":"2016","unstructured":"Wurtz P, Wang Q, Soininen P, Kangas AJ, Fatemifar G, Tynkkynen T, et al. Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase. J Am Coll Cardiol. 2016;67(10):1200\u201310. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.060.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1342_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jacc.2005.09.053","volume":"47","author":"AK Vyas","year":"2006","unstructured":"Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, et al. Reduction in ventricular tachyarrhythmias with statins in the multicenter automatic defibrillator implantation trial (MADIT)-II. J Am Coll Cardiol. 2006;47(4):769\u201373. https:\/\/doi.org\/10.1016\/j.jacc.2005.09.053.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"1342_CR47","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.109.849117","volume":"120","author":"JJ McMurray","year":"2009","unstructured":"McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, et al. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the controlled Rosuvastatin multinational trial in heart failure (CORONA): a retrospective analysis. Circulation. 2009;120(22):2188\u201396. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.849117.","journal-title":"Circulation"},{"issue":"7","key":"1342_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","volume":"108","author":"K Node","year":"2003","unstructured":"Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation. 2003;108(7):839\u201343. https:\/\/doi.org\/10.1161\/01.CIR.0000084539.58092.DE.","journal-title":"Circulation"},{"issue":"9645","key":"1342_CR49","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","volume":"372","author":"L Tavazzi","year":"2008","unstructured":"Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, et al. Effect of Rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1231\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(08)61240-4.","journal-title":"Lancet"},{"issue":"1","key":"1342_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jvs.2014.05.093","volume":"61","author":"BD Suckow","year":"2015","unstructured":"Suckow BD, Kraiss LW, Schanzer A, Stone DH, Kalish J, DeMartino RR, et al. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. J Vasc Surg. 2015;61(1):126\u201333. https:\/\/doi.org\/10.1016\/j.jvs.2014.05.093.","journal-title":"J Vasc Surg"},{"issue":"2","key":"1342_CR51","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jvs.2017.03.416","volume":"66","author":"TFX O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell TFX, Deery SE, Darling JD, Shean KE, Mittleman MA, Yee GN, et al. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia. J Vasc Surg. 2017;66(2):572\u20138. https:\/\/doi.org\/10.1016\/j.jvs.2017.03.416.","journal-title":"J Vasc Surg"},{"issue":"5","key":"1342_CR52","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4274\/balkanmedj.galenos.2023.2023-5-26","volume":"40","author":"O Birdal","year":"2023","unstructured":"Birdal O, Sayg\u0131 M, Do\u011fan R, Tezen O, Karag\u00f6z A, Tanbo\u011fa \u0130. Risk of venous thromboembolism with statins: evidence gathered via a network meta-analysis. Balkan Med J. 2023;40(5):324\u201332. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2023.2023-5-26.","journal-title":"Balkan Med J"},{"issue":"2","key":"1342_CR53","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S2352-3026(16)30184-3","volume":"4","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Seidu S, Khunti K. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol. 2017;4(2):e83\u201393. https:\/\/doi.org\/10.1016\/S2352-3026(16)30184-3.","journal-title":"Lancet Haematol"},{"issue":"9841","key":"1342_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","volume":"380","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380(9841):565\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(12)61190-8.","journal-title":"Lancet"},{"issue":"22","key":"1342_CR55","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","volume":"391","author":"PM Ridker","year":"2024","unstructured":"Ridker PM, Moorthy MV, Cook NR, Rifai N, Lee IM, Buring JE, Inflammation. Cholesterol, Lipoprotein(a), and 30-Year cardiovascular outcomes in women. N Engl J Med. 2024;391(22):2087\u201397. https:\/\/doi.org\/10.1056\/NEJMoa2405182.","journal-title":"N Engl J Med"},{"issue":"13","key":"1342_CR56","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","volume":"132","author":"EA Bohula","year":"2015","unstructured":"Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, et al. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of Ezetimibe to Simvastatin and associated with better outcomes in IMPROVE-IT. Circulation. 2015;132(13):1224\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018381.","journal-title":"Circulation"},{"issue":"4","key":"1342_CR57","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/cvr\/cvae034","volume":"120","author":"S Xie","year":"2024","unstructured":"Xie S, Galimberti F, Olmastroni E, Luscher TF, Carugo S, Catapano AL, et al. Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials. Cardiovasc Res. 2024;120(4):333\u201344. https:\/\/doi.org\/10.1093\/cvr\/cvae034.","journal-title":"Cardiovasc Res"},{"key":"1342_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1874192401812010029","volume":"12","author":"A Reklou","year":"2018","unstructured":"Reklou A, Doumas M, Imprialos K, Stavropoulos K, Patoulias D, Athyros VG. Reduction of vascular inflammation, LDL-C, or both for the protection from cardiovascular events?? Open Cardiovasc Med J. 2018;12:29\u201340. https:\/\/doi.org\/10.2174\/1874192401812010029.","journal-title":"Open Cardiovasc Med J"},{"issue":"3","key":"1342_CR59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCOUTCOMES.109.868299","volume":"2","author":"PM Ridker","year":"2009","unstructured":"Ridker PM. The JUPITER trial: results, controversies, and implications for prevention. Circ Cardiovasc Qual Outcomes. 2009;2(3):279\u201385. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.109.868299.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"1342_CR60","doi-asserted-by":"publisher","first-page":"236","DOI":"10.7150\/ijbs.8.236","volume":"8","author":"F Su","year":"2012","unstructured":"Su F, Shi M, Yan Z, Ou D, Li J, Lu Z, et al. Simvastatin modulates remodeling of Kv4.3 expression in rat hypertrophied cardiomyocytes. Int J Biol Sci. 2012;8(2):236\u201348. https:\/\/doi.org\/10.7150\/ijbs.8.236.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"1342_CR61","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1089\/ars.2013.5542","volume":"20","author":"AC Pinho-Gomes","year":"2014","unstructured":"Pinho-Gomes AC, Reilly S, Brandes RP, Casadei B. Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. Antioxid Redox Signal. 2014;20(8):1268\u201385. https:\/\/doi.org\/10.1089\/ars.2013.5542.","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"1342_CR62","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.amjcard.2009.07.045","volume":"104","author":"A Vedre","year":"2009","unstructured":"Vedre A, Gurm HS, Froehlich JB, Kline-Rogers E, Montalescot G, Gore JM, et al. Impact of prior Statin therapy on arrhythmic events in patients with acute coronary syndromes (from the global registry of acute coronary events [GRACE]). Am J Cardiol. 2009;104(12):1613\u20137. https:\/\/doi.org\/10.1016\/j.amjcard.2009.07.045.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1342_CR63","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jacc.2005.06.088","volume":"47","author":"S Sola","year":"2006","unstructured":"Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol. 2006;47(2):332\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2005.06.088.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1342_CR64","doi-asserted-by":"publisher","first-page":"100385","DOI":"10.1016\/j.jacadv.2023.100385","volume":"2","author":"JL Anderson","year":"2023","unstructured":"Anderson JL, May HT, Le VT, Muhlestein JB, Horne BD, Bair TL, et al. Impact of Statin therapy in heart failure patients: results of a large Real-World experience. JACC Adv. 2023;2(4):100385. https:\/\/doi.org\/10.1016\/j.jacadv.2023.100385.","journal-title":"JACC Adv"},{"issue":"2","key":"1342_CR65","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jvs.2003.08.030","volume":"39","author":"PK Henke","year":"2004","unstructured":"Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalin S, et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg. 2004;39(2):357\u201365. https:\/\/doi.org\/10.1016\/j.jvs.2003.08.030.","journal-title":"J Vasc Surg"},{"issue":"2","key":"1342_CR66","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jvs.2011.08.044","volume":"55","author":"FA Aiello","year":"2012","unstructured":"Aiello FA, Khan AA, Meltzer AJ, Gallagher KA, McKinsey JF, Schneider DB. Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg. 2012;55(2):371\u20139. https:\/\/doi.org\/10.1016\/j.jvs.2011.08.044. discussion 80.","journal-title":"J Vasc Surg"},{"issue":"4","key":"1342_CR67","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jvs.2011.10.128","volume":"55","author":"JJ Siracuse","year":"2012","unstructured":"Siracuse JJ, Giles KA, Pomposelli FB, Hamdan AD, Wyers MC, Chaikof EL, et al. Results for primary bypass versus primary angioplasty\/stent for intermittent claudication due to superficial femoral artery occlusive disease. J Vasc Surg. 2012;55(4):1001\u20137. https:\/\/doi.org\/10.1016\/j.jvs.2011.10.128.","journal-title":"J Vasc Surg"},{"issue":"2","key":"1342_CR68","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jvs.2014.02.012","volume":"60","author":"JJ Siracuse","year":"2014","unstructured":"Siracuse JJ, Gill HL, Cassidy SP, Messina MD, Catz D, Egorova N, et al. Endovascular treatment of lesions in the below-knee popliteal artery. J Vasc Surg. 2014;60(2):356\u201361. https:\/\/doi.org\/10.1016\/j.jvs.2014.02.012.","journal-title":"J Vasc Surg"},{"issue":"6","key":"1342_CR69","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jvs.2003.12.027","volume":"39","author":"TA Abbruzzese","year":"2004","unstructured":"Abbruzzese TA, Havens J, Belkin M, Donaldson MC, Whittemore AD, Liao JK, et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg. 2004;39(6):1178\u201385. https:\/\/doi.org\/10.1016\/j.jvs.2003.12.027.","journal-title":"J Vasc Surg"},{"issue":"4","key":"1342_CR70","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jvs.2011.04.021","volume":"54","author":"ST Scali","year":"2011","unstructured":"Scali ST, Beck AW, Nolan BW, Stone DH, De Martino RR, Chang CK, et al. Completion duplex ultrasound predicts early graft thrombosis after crural bypass in patients with critical limb ischemia. J Vasc Surg. 2011;54(4):1006\u201310. https:\/\/doi.org\/10.1016\/j.jvs.2011.04.021.","journal-title":"J Vasc Surg"},{"issue":"14","key":"1342_CR71","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jacc.2010.10.047","volume":"57","author":"DD Waters","year":"2011","unstructured":"Waters DD, Ho JE, DeMicco DA, Breazna A, Arsenault BJ, Wun CC, et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J Am Coll Cardiol. 2011;57(14):1535\u201345. https:\/\/doi.org\/10.1016\/j.jacc.2010.10.047.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1342_CR72","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/01.asn.0000068461.45784.2f","volume":"14","author":"M Tonelli","year":"2003","unstructured":"Tonelli M, Moy\u00e9 L, Sacks FM, Cole T, Curhan GC, Investigators CRET. Effect of Pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol. 2003;14(6):1605\u201313. https:\/\/doi.org\/10.1097\/01.asn.0000068461.45784.2f.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1342_CR73","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ahj.2014.08.005","volume":"168","author":"M Leoncini","year":"2014","unstructured":"Leoncini M, Toso A, Maioli M, Tropeano F, Badia T, Villani S, et al. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study. Am Heart J. 2014;168(5):792\u20137. https:\/\/doi.org\/10.1016\/j.ahj.2014.08.005.","journal-title":"Am Heart J"},{"issue":"3","key":"1342_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40256-016-0164-5","volume":"16","author":"H Li","year":"2016","unstructured":"Li H, Wang C, Liu C, Li R, Zou M, Cheng G. Efficacy of short-term statin treatment for the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography\/percutaneous coronary intervention: a meta-analysis of 21 randomized controlled trials. Am J Cardiovasc Drugs. 2016;16(3):201\u201319. https:\/\/doi.org\/10.1007\/s40256-016-0164-5.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"18","key":"1342_CR75","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","volume":"374","author":"Z Zheng","year":"2016","unstructured":"Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, et al. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374(18):1744\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1507750.","journal-title":"N Engl J Med"},{"issue":"3","key":"1342_CR76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1440-1797.2011.01546.x","volume":"17","author":"JR Prowle","year":"2012","unstructured":"Prowle JR, Calzavacca P, Licari E, Ligabo EV, Echeverri JE, Haase M, et al. Pilot double-blind, randomized controlled trial of short-term Atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology. 2012;17(3):215\u201324. https:\/\/doi.org\/10.1111\/j.1440-1797.2011.01546.x.","journal-title":"Nephrology"},{"issue":"9","key":"1342_CR77","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/jama.2016.0548","volume":"315","author":"FT Billings","year":"2016","unstructured":"Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, et al. High-dose perioperative Atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315(9):877\u201388. https:\/\/doi.org\/10.1001\/jama.2016.0548.","journal-title":"JAMA"},{"key":"1342_CR78","doi-asserted-by":"publisher","first-page":"205435811878915","DOI":"10.1177\/2054358118789158","volume":"5","author":"RK Hsu","year":"2018","unstructured":"Hsu RK, Truwit JD, Matthay MA, Levitt JE, Thompson BT, Liu KD. Effect of rosuvastatin on acute kidney injury in sepsis-associated acute respiratory distress syndrome. Can J Kidney Health Dis. 2018;5:2054358118789158. https:\/\/doi.org\/10.1177\/2054358118789158.","journal-title":"Can J Kidney Health Dis"},{"issue":"4 Suppl 2","key":"1342_CR79","first-page":"A120","volume":"130","author":"PD Higgins","year":"2006","unstructured":"Higgins PD, Khan T, Mapili J, Zimmermann EM. Atorvastatin decreases Seo index in patients with short duration of disease in ulcerative colitis: a randomized placebo-controlled clinical trial. Gastroenterology. 2006;130(4 Suppl 2):A120.","journal-title":"Gastroenterology"},{"issue":"2","key":"1342_CR80","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12664-013-0420-4","volume":"33","author":"P Dhamija","year":"2014","unstructured":"Dhamija P, Hota D, Kochhar R, Sachdev A, Chakrabarti A. Randomized clinical trial: Atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis. Indian J Gastroenterol. 2014;33(2):151\u20136. https:\/\/doi.org\/10.1007\/s12664-013-0420-4.","journal-title":"Indian J Gastroenterol"},{"issue":"8","key":"1342_CR81","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/jama.2012.8439","volume":"308","author":"D Preiss","year":"2012","unstructured":"Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, et al. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA. 2012;308(8):804\u201311. https:\/\/doi.org\/10.1001\/jama.2012.8439.","journal-title":"JAMA"},{"issue":"1","key":"1342_CR82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/ajg.2010.299","volume":"106","author":"T Foster","year":"2011","unstructured":"Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis heart study randomized clinical trial. Am J Gastroenterol. 2011;106(1):71\u20137. https:\/\/doi.org\/10.1038\/ajg.2010.299.","journal-title":"Am J Gastroenterol"},{"issue":"25","key":"1342_CR83","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1016\/j.jacc.2021.04.075","volume":"77","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Ryan J, Ernst ME, Zoungas S, Tonkin AM, Woods RL, et al. Effect of Statin therapy on cognitive decline and incident dementia in older adults. J Am Coll Cardiol. 2021;77(25):3145\u201356. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.075.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1342_CR84","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549\u201359. https:\/\/doi.org\/10.1056\/NEJMoa061894.","journal-title":"N Engl J Med"},{"issue":"8","key":"1342_CR85","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2304146","volume":"389","author":"SK Grinspoon","year":"2023","unstructured":"Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, et al. Pitavastatin to prevent cardiovascular disease in HIV infection. N Engl J Med. 2023;389(8):687\u201399. https:\/\/doi.org\/10.1056\/NEJMoa2304146.","journal-title":"N Engl J Med"},{"issue":"6","key":"1342_CR86","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1001\/jama.2023.11887","volume":"330","author":"TG Neilan","year":"2023","unstructured":"Neilan TG, Quinaglia T, Onoue T, Mahmood SS, Drobni ZD, Gilman HK, et al. Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial. JAMA. 2023;330(6):528\u201336. https:\/\/doi.org\/10.1001\/jama.2023.11887.","journal-title":"JAMA"},{"issue":"2","key":"1342_CR87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaccao.2024.11.008","volume":"7","author":"V Juhasz","year":"2025","unstructured":"Juhasz V, Quinaglia T, Drobni ZD, Heemelaar JC, Neuberg DS, Han Y, et al. Atorvastatin and myocardial extracellular volume expansion during anthracycline-based chemotherapy. JACC: CardioOncology. 2025;7(2):125\u201337. https:\/\/doi.org\/10.1016\/j.jaccao.2024.11.008.","journal-title":"JACC: CardioOncology"},{"issue":"1","key":"1342_CR88","doi-asserted-by":"publisher","first-page":"e29849","DOI":"10.1371\/journal.pone.0029849","volume":"7","author":"C Cholesterol Treatment Trialists","year":"2012","unstructured":"Cholesterol Treatment Trialists C, Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, et al. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One. 2012;7(1):e29849. https:\/\/doi.org\/10.1371\/journal.pone.0029849.","journal-title":"PLoS One"},{"issue":"2","key":"1342_CR89","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/archinte.164.2.146","volume":"164","author":"DC Bauer","year":"2004","unstructured":"Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Ensrud KE, et al. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med. 2004;164(2):146\u201352. https:\/\/doi.org\/10.1001\/archinte.164.2.146.","journal-title":"Arch Intern Med"},{"issue":"9426","key":"1342_CR90","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","volume":"363","author":"DW McCarey","year":"2004","unstructured":"McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, et al. Trial of Atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet. 2004;363(9426):2015\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(04)16449-0.","journal-title":"Lancet"},{"issue":"7","key":"1342_CR91","doi-asserted-by":"publisher","first-page":"E367","DOI":"10.1503\/cmaj.111017","volume":"184","author":"V Novack","year":"2012","unstructured":"Novack V, MacFadyen J, Malhotra A, Almog Y, Glynn RJ, Ridker PM. The effect of Rosuvastatin on incident pneumonia: results from the JUPITER trial. CMAJ. 2012;184(7):E367\u201372. https:\/\/doi.org\/10.1503\/cmaj.111017.","journal-title":"CMAJ"},{"issue":"9","key":"1342_CR92","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","volume":"144","author":"M D\u00f6bert","year":"2021","unstructured":"D\u00f6bert M, Varouxaki AN, Mu AC, Syngelaki A, Ciobanu A, Akolekar R, et al. Pravastatin versus placebo in pregnancies at high risk of term preeclampsia. Circulation. 2021;144(9):670\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053963.","journal-title":"Circulation"},{"issue":"25","key":"1342_CR93","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.jacc.2013.08.1627","volume":"62","author":"S Subramanian","year":"2013","unstructured":"Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM, et al. High-dose Atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of Statins. J Am Coll Cardiol. 2013;62(25):2382\u201391. https:\/\/doi.org\/10.1016\/j.jacc.2013.08.1627.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1342_CR94","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ijir.2012.46","volume":"25","author":"AA El-Sisi","year":"2013","unstructured":"El-Sisi AA, Hegazy SK, Salem KA, AbdElkawy KS. Atorvastatin improves erectile dysfunction in patients initially irresponsive to sildenafil by the activation of endothelial nitric oxide synthase. Int J Impot Res. 2013;25(4):143\u20138. https:\/\/doi.org\/10.1038\/ijir.2012.46.","journal-title":"Int J Impot Res"},{"issue":"543","key":"1342_CR95","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1080\/01621459.2022.2157727","volume":"118","author":"X Guo","year":"2023","unstructured":"Guo X, Wei W, Liu M, Cai T, Wu C, Wang J. Assessing the most vulnerable subgroup to type II diabetes associated with statin usage: evidence from electronic health record data. J Am Stat Assoc. 2023;118(543):1488\u201399. https:\/\/doi.org\/10.1080\/01621459.2022.2157727.","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"1342_CR96","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","volume":"58","author":"H Cederberg","year":"2015","unstructured":"Cederberg H, Stan\u010d\u00e1kov\u00e1 A, Yaluri N, Modi S, Kuusisto J, Laakso M. Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort. Diabetologia. 2015;58(5):1109\u201317. https:\/\/doi.org\/10.1007\/s00125-015-3528-5.","journal-title":"Diabetologia"},{"issue":"1","key":"1342_CR97","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12882-022-02815-6","volume":"23","author":"A Wang","year":"2022","unstructured":"Wang A, Lin Y, Liang B, Zhao X, Qiu M, Huang H, et al. Statins attenuate cholesterol-induced ROS via inhibiting NOX2\/NOX4 and mitochondrial pathway in collecting ducts of the kidney. BMC Nephrol. 2022;23(1):184. https:\/\/doi.org\/10.1186\/s12882-022-02815-6.","journal-title":"BMC Nephrol"},{"issue":"6","key":"1342_CR98","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/ibd.21822","volume":"18","author":"SD Crockett","year":"2012","unstructured":"Crockett SD, Hansen RA, St\u00fcrmer T, Schectman R, Darter J, Sandler RS, et al. Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2012;18(6):1048\u201356. https:\/\/doi.org\/10.1002\/ibd.21822.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"1342_CR99","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/ajg.2016.233","volume":"111","author":"R Ungaro","year":"2016","unstructured":"Ungaro R, Chang HL, C\u00f4t\u00e9-Daigneault J, Mehandru S, Atreja A, Colombel JF. Statins associated with decreased risk of new onset inflammatory bowel disease. Am J Gastroenterol. 2016;111(10):1416\u201323. https:\/\/doi.org\/10.1038\/ajg.2016.233.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1342_CR100","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/aje\/kwq361","volume":"173","author":"R Erichsen","year":"2011","unstructured":"Erichsen R, Fr\u00f8slev T, Lash TL, Pedersen L, S\u00f8rensen HT. Long-term Statin use and the risk of gallstone disease: A population-based case-control study. Am J Epidemiol. 2011;173(2):162\u201370. https:\/\/doi.org\/10.1093\/aje\/kwq361.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1342_CR101","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11883-025-01298-8","volume":"27","author":"MS Safarova","year":"2025","unstructured":"Safarova MS, Weintraub S, Sadaniantz K, Kovell L, Warden BA, Garshick MS, et al. Statin use in special populations for the prevention of cardiovascular disease in adults. Curr Atheroscler Rep. 2025;27(1):54. https:\/\/doi.org\/10.1007\/s11883-025-01298-8.","journal-title":"Curr Atheroscler Rep"},{"issue":"7808","key":"1342_CR102","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","volume":"581","author":"S Vieira-Silva","year":"2020","unstructured":"Vieira-Silva S, Falony G, Belda E, Nielsen T, Aron-Wisnewsky J, Chakaroun R, et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature. 2020;581(7808):310\u20135. https:\/\/doi.org\/10.1038\/s41586-020-2269-x.","journal-title":"Nature"},{"issue":"1","key":"1342_CR103","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jacl.2020.10.007","volume":"15","author":"A Adhikari","year":"2021","unstructured":"Adhikari A, Tripathy S, Chuzi S, Peterson J, Stone NJ. Association between Statin use and cognitive function: A systematic review of randomized clinical trials and observational studies. J Clin Lipidol. 2021;15(1):22\u2013e3212. https:\/\/doi.org\/10.1016\/j.jacl.2020.10.007.","journal-title":"J Clin Lipidol"},{"issue":"16","key":"1342_CR104","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1212\/01.wnl.0000346751.39886.01","volume":"72","author":"MR Goldstein","year":"2009","unstructured":"Goldstein MR, Mascitelli L, Pezzetta F. Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology. 2009;72(16):1448. https:\/\/doi.org\/10.1212\/01.wnl.0000346751.39886.01.","journal-title":"Neurology"},{"issue":"4","key":"1342_CR105","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1161\/STROKEAHA.119.027301","volume":"51","author":"AR Ribe","year":"2020","unstructured":"Ribe AR, Vestergaard CH, Vestergaard M, Pedersen HS, Prior A, Lietzen LW, et al. Statins and risk of intracerebral hemorrhage in individuals with a history of stroke. Stroke. 2020;51(4):1111\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027301.","journal-title":"Stroke"},{"issue":"2","key":"1342_CR106","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/STROKEAHA.121.035846","volume":"53","author":"P Amarenco","year":"2022","unstructured":"Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lavallee PC, et al. Intracranial hemorrhage in the TST trial. Stroke. 2022;53(2):457\u201362. https:\/\/doi.org\/10.1161\/STROKEAHA.121.035846.","journal-title":"Stroke"},{"issue":"1","key":"1342_CR107","doi-asserted-by":"publisher","first-page":"e2564","DOI":"10.1038\/cddis.2016.418","volume":"8","author":"C Henninger","year":"2017","unstructured":"Henninger C, Fritz G. Statins in anthracycline-induced cardiotoxicity: Rac and rho, and the heartbreakers. Cell Death Dis. 2017;8(1):e2564. https:\/\/doi.org\/10.1038\/cddis.2016.418.","journal-title":"Cell Death Dis"},{"key":"1342_CR108","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.preghy.2020.11.014","volume":"23","author":"A Vahedian-Azimi","year":"2021","unstructured":"Vahedian-Azimi A, Karimi L, Reiner Z, Makvandi S, Sahebkar A. Effects of Statins on preeclampsia: A systematic review. Pregnancy Hypertens. 2021;23:123\u201330. https:\/\/doi.org\/10.1016\/j.preghy.2020.11.014.","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"1342_CR109","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/HYPERTENSIONAHA.123.22457","volume":"81","author":"L Tan","year":"2024","unstructured":"Tan L, Kluivers ACM, Cruz-Lopez EO, Broekhuizen M, Chen Z, Neuman RI, et al. Statins prevent the deleterious consequences of placental chemerin upregulation in preeclampsia. Hypertension. 2024;81(4):861\u201375. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.22457.","journal-title":"Hypertension"},{"issue":"22","key":"1342_CR110","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018338","volume":"9","author":"F Peters","year":"2020","unstructured":"Peters F, Kuchenbecker J, Kreutzburg T, Marschall U, Debus ES, Behrendt CA. Long-term effectiveness and safety of initiating statin therapy after index revascularization in patients with peripheral arterial occlusive disease. J Am Heart Assoc. 2020;9(22):e018338. https:\/\/doi.org\/10.1161\/JAHA.120.018338.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"1342_CR111","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/CIRCINTERVENTIONS.113.000274","volume":"6","author":"TR Vogel","year":"2013","unstructured":"Vogel TR, Dombrovskiy VY, Gali\u00f1anes EL, Kruse RL. Preoperative statins and limb salvage after lower extremity revascularization in the medicare population. Circ Cardiovasc Interv. 2013;6(6):694\u2013700. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.113.000274.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"1342_CR112","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","volume":"40","author":"B Uzzan","year":"2007","unstructured":"Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Effects of statins on bone mineral density: a meta-analysis of clinical studies. Bone. 2007;40(6):1581\u20137. https:\/\/doi.org\/10.1016\/j.bone.2007.02.019.","journal-title":"Bone"},{"issue":"9","key":"1342_CR113","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1210\/jc.2018-00652","volume":"103","author":"SM Lin","year":"2018","unstructured":"Lin SM, Wang JH, Liang CC, Huang HK. Statin use is associated with decreased osteoporosis and fracture risks in stroke patients. J Clin Endocrinol Metab. 2018;103(9):3439\u201348. https:\/\/doi.org\/10.1210\/jc.2018-00652.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1342_CR114","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.amjmed.2012.04.011","volume":"125","author":"V Chopra","year":"2012","unstructured":"Chopra V, Rogers MA, Buist M, Govindan S, Lindenauer PK, Saint S, et al. Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis. Am J Med. 2012;125(11):1111\u201323. https:\/\/doi.org\/10.1016\/j.amjmed.2012.04.011.","journal-title":"Am J Med"},{"issue":"4","key":"1342_CR115","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/s-0040-1722307","volume":"47","author":"D Onorato","year":"2021","unstructured":"Onorato D, Pucci M, Carpene G, Henry BM, Sanchis-Gomar F, Lippi G. Protective effects of statins administration in European and North American patients infected with COVID-19: a meta-analysis. Semin Thromb Hemost. 2021;47(4):392\u20139. https:\/\/doi.org\/10.1055\/s-0040-1722307.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"1342_CR116","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1161\/ATVBAHA.117.310052","volume":"38","author":"C Labos","year":"2018","unstructured":"Labos C, Brophy JM, Smith GD, Sniderman AD, Thanassoulis G. Evaluation of the pleiotropic effects of statins: a reanalysis of the randomized trial evidence using Egger regression-brief report. Arterioscler Thromb Vasc Biol. 2018;38(1):262\u20135. https:\/\/doi.org\/10.1161\/ATVBAHA.117.310052.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5\u20136","key":"1342_CR117","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3727\/105221613x13571653093240","volume":"15","author":"DJ Garnett","year":"2012","unstructured":"Garnett DJ, Greenhough TJ. Statins cause profound effects on gene expression in human cancer cells in vitro: the role of membrane microdomains. Gene Expr. 2012;15(5\u20136):225\u201334. https:\/\/doi.org\/10.3727\/105221613x13571653093240.","journal-title":"Gene Expr"},{"key":"1342_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113304","volume":"153","author":"A Mahmoudi","year":"2022","unstructured":"Mahmoudi A, Heydari S, Markina YV, Barreto GE, Sahebkar A. Role of statins in regulating molecular pathways following traumatic brain injury: a system pharmacology study. Biomed Pharmacother. 2022;153:113304. https:\/\/doi.org\/10.1016\/j.biopha.2022.113304.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1342_CR119","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12916-021-02013-5","volume":"19","author":"S Li","year":"2021","unstructured":"Li S, Schooling CM. A phenome-wide association study of genetically mimicked statins. BMC Med. 2021;19(1):151. https:\/\/doi.org\/10.1186\/s12916-021-02013-5.","journal-title":"BMC Med"},{"issue":"1","key":"1342_CR120","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017;120(1):229\u201343. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308537.","journal-title":"Circ Res"}],"updated-by":[{"DOI":"10.1007\/s11883-026-01397-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000}}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01342-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-025-01342-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-025-01342-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:19:04Z","timestamp":1771305544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-025-01342-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1007\/s11883-025-01342-7","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated to include the following acknowledgement in the captions of Figures 1 and 2: 'Figure created with BioRender.com.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11883-026-01397-0","URL":"https:\/\/doi.org\/10.1007\/s11883-026-01397-0","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}